Autologous lung spheroid cells (BreStem Therapeutics)

N/A

Report date: 2024/06/24 11:33:20

Base Information

Drug NameAutologous lung spheroid cells (BreStem Therapeutics)
Drug Alias NameAutologous LSCs (BreStem Therapeutics)BRS-101BRS101
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBreStem Therapeutics IncNorth Carolina State University
China Registration ClassN/A

Develop Information

Active CompaniesBreStem Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A